Panelists 3260

Christa Bähr is head of the life sciences equity research team at DZ Bank (Frankfurt, Germany), an investment banking firm that covers European life sciences companies with a special focus on German small- and midcaps. The firm focuses its research activities on the healthcare sector, paying particular attention to medical technology, biotechnology, pharmaceuticals, and agrochemicals.

Timothy A. Dugan is a partner at One Equity Partners (Chicago), a leading private investor in healthcare companies. The firm focuses its investment activity around medical products and devices in companies with revenues between $50 million and $500 million.

Thomas J. Gunderson is managing director and senior research analyst for medical technology at U.S. Bancorp Piper Jaffray (Minneapolis).

Manoj Kenkare is research manager for the healthcare and life sciences practice at Frost & Sullivan (San Antonio, TX). His field of expertise is in the area of life sciences, particularly drug-discovery technologies, clinical diagnostics, medical devices, and healthcare IT.

Joseph Kozikowski, MD, is managing partner of Proformant Inc. (Framingham, MA), a corporate-development consultancy focused on building public and private medical technology companies. His expertise is the creation of shareholder value with new medical technologies.